Skip to main content
SpringerLink
Log in

Trendumkehr in der Arzneimittelforschung

  • Published:
Naturwissenschaften Aims and scope Submit manuscript

Abstract

The author gives a breakdown of costs for industrial drug research and development of seven German drug companies. Trends of development and fields of interdisciplinary pharmaceutical research are described. Increasing expenditures and requirements for safety and efficacy reduce the chances of innnovation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Gross, F.: V. Kolloquium für Klinische Pharmakologie und Experimentelle Therapie, Göttingen 1976; Broschüre der Paul-Martini-Stiftung der Medizinisch Pharmazeutischen Studiengesellschaft e.V., Frankfurt/Main (im Druck)

  2. Rahn, K.H.: mb der arzt 10, 518 (1976)

    Google Scholar 

  3. Schwartzman, D.: American Enterprise Institute for Public Policy Research, Washington, D.C., 1975

  4. European Workshop Towards a More Rational Regulation of the Development of New Medicines, Sestri Levante 1976; Eur. J. Clin. Pharm. 11, 233 (1977)

    Google Scholar 

  5. Gross, F.: Clin. Pharmacol. Ther. 19, 1 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. E. Merck, D-6100, Darmstadt

    Jan Thesing

Authors
  1. Jan Thesing
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thesing, J. Trendumkehr in der Arzneimittelforschung. Naturwissenschaften 64, 601–605 (1977). https://doi.org/10.1007/BF00440091

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00440091

Search

Navigation